Leukemic phase of anaplastic lymphoma kinase positive, anaplastic large cell lymphoma

Indian J Pathol Microbiol. 2011 Jul-Sep;54(3):599-602. doi: 10.4103/0377-4929.85108.

Abstract

Anaplastic large cell lymphoma (ALCL) is a distinct type of CD30+ T/null-cell non-Hodgkin's lymphoma that frequently involves nodal and extranodal sites. The presence of leukemic phase in ALCL is extremely rare and occurs exclusively with ALK1-positive ALCL. We describe two patients with ALK1-positive ALCL who developed a leukemic phase with rapid progression of the disease. Immunophenotypic pattern assessed on peripheral blood by flow cytometry revealed CD45, CD30, and CD25 positivity in both cases but NPM-ALK1 was expressed in only one case. Both patients developed leukemic phase as a terminal event of the disease and we share the immunophenotypic features of both cases.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anaplastic Lymphoma Kinase
  • Child
  • Disease Progression
  • Female
  • Flow Cytometry
  • Humans
  • Interleukin-2 Receptor alpha Subunit / analysis
  • Ki-1 Antigen / analysis
  • Leukemia, Lymphoid / diagnosis*
  • Leukemia, Lymphoid / pathology*
  • Leukocyte Common Antigens / analysis
  • Leukocytes, Mononuclear / chemistry
  • Lymphoma, Large-Cell, Anaplastic / complications
  • Lymphoma, Large-Cell, Anaplastic / diagnosis*
  • Lymphoma, Large-Cell, Anaplastic / pathology*
  • Male
  • Receptor Protein-Tyrosine Kinases / metabolism*

Substances

  • IL2RA protein, human
  • Interleukin-2 Receptor alpha Subunit
  • Ki-1 Antigen
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases
  • Leukocyte Common Antigens
  • PTPRC protein, human